DexCom, Inc.

DXCM

$58.49

Name : DexCom, Inc.

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $22,937,161,728.00

EPSttm : 1.8

DexCom, Inc.

$58.49

0.74%

$0.43

Float Short %

2.93

Margin Of Safety %

Put/Call OI Ratio

0.76

EPS Next Q Diff

-0.14

EPS Last/This Y

0.61

EPS This/Next Y

0.41

Price

58.47

Target Price

86.04

Analyst Recom

1.45

Performance Q

-27.7

Relative Volume

0.98

Beta

1.52

Ticker: DXCM

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-10-20	DXCM	68.43	0.77	0.12	194028
2025-10-21	DXCM	69.76	0.75	0.16	198487
2025-10-22	DXCM	70.69	0.74	0.22	199470
2025-10-23	DXCM	71.06	0.75	0.40	200368
2025-10-24	DXCM	70.33	0.75	0.44	200824
2025-10-27	DXCM	70.66	0.78	0.42	187262
2025-10-28	DXCM	69.25	0.81	0.82	187163
2025-10-29	DXCM	68.22	0.82	0.26	193613
2025-10-30	DXCM	68.19	0.78	0.42	200610
2025-10-31	DXCM	58.19	0.71	2.24	243632
2025-11-03	DXCM	60.42	0.76	0.90	205414
2025-11-04	DXCM	61.18	0.75	1.22	208336
2025-11-05	DXCM	59.28	0.74	0.92	209461
2025-11-06	DXCM	58.02	0.73	7.47	213359
2025-11-07	DXCM	54.99	0.71	2.14	214792
2025-11-10	DXCM	54.82	0.76	0.58	212343
2025-11-11	DXCM	58.1	0.76	0.72	214590
2025-11-12	DXCM	59.59	0.75	2.51	217824
2025-11-13	DXCM	59.68	0.75	4.58	219750
2025-11-14	DXCM	58.05	0.75	1.41	221481
2025-11-17	DXCM	58.46	0.76	3.30	213893
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-10-20	DXCM	68.43	26.3	232.0	2.05
2025-10-21	DXCM	69.77	26.3	224.0	2.05
2025-10-22	DXCM	70.70	26.3	217.9	2.05
2025-10-23	DXCM	71.06	26.1	209.2	2.05
2025-10-24	DXCM	70.32	26.1	193.4	2.05
2025-10-27	DXCM	70.64	26.1	208.5	2.05
2025-10-28	DXCM	69.23	26.1	183.8	2.05
2025-10-29	DXCM	68.17	26.1	188.3	2.05
2025-10-30	DXCM	68.20	26.1	204.3	2.05
2025-10-31	DXCM	58.22	26.1	54.7	2.05
2025-11-03	DXCM	60.40	46.7	68.2	2.05
2025-11-04	DXCM	61.13	44.2	2.8	2.07
2025-11-05	DXCM	59.28	44.2	-40.1	2.07
2025-11-06	DXCM	58.03	43.8	-44.5	2.07
2025-11-07	DXCM	55.00	43.8	-75.2	2.07
2025-11-10	DXCM	54.84	43.8	-26.7	2.07
2025-11-11	DXCM	58.13	43.8	35.5	2.07
2025-11-12	DXCM	59.60	43.8	1.1	2.07
2025-11-13	DXCM	59.72	43.8	-22.0	2.07
2025-11-14	DXCM	58.04	43.8	-51.5	2.07
2025-11-17	DXCM	58.47	43.8	-16.7	2.07
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-10-20	DXCM	-0.77	-0.27	3.38
2025-10-21	DXCM	-0.77	-0.27	3.38
2025-10-22	DXCM	-0.77	-0.27	3.38
2025-10-23	DXCM	-0.77	-0.27	3.38
2025-10-24	DXCM	-0.77	-0.27	3.38
2025-10-27	DXCM	-0.77	-0.19	3.00
2025-10-28	DXCM	-0.77	-0.19	3.00
2025-10-29	DXCM	-0.77	-0.19	3.00
2025-10-30	DXCM	-0.77	-0.19	3.00
2025-10-31	DXCM	-0.77	-0.19	3.00
2025-11-03	DXCM	-0.78	-1.17	3.02
2025-11-04	DXCM	-0.77	-1.17	3.02
2025-11-05	DXCM	-0.77	-1.17	3.02
2025-11-06	DXCM	-0.77	-1.17	3.02
2025-11-07	DXCM	-0.77	-1.17	3.02
2025-11-10	DXCM	-0.77	-3.20	3.02
2025-11-11	DXCM	-0.51	-3.20	3.02
2025-11-12	DXCM	-0.51	-3.20	2.91
2025-11-13	DXCM	-0.53	-3.20	2.91
2025-11-14	DXCM	-0.53	-3.20	2.91
2025-11-17	DXCM	-0.53	-2.97	2.93
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.61

Avg. EPS Est. Current Quarter

0.65

Avg. EPS Est. Next Quarter

0.47

Insider Transactions

-0.53

Institutional Transactions

-2.97

Beta

1.52

Average Sales Estimate Current Quarter

1242

Average Sales Estimate Next Quarter

1178

Fair Value

78.65

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

64.5

Max Drawdown 5-Year %

-66.3

Target Price

86.04

P/E

32.55

Forward P/E

23.62

PEG

1.5

P/S

5.05

P/B

8.37

P/Free Cash Flow

21.48

EPS

1.8

Average EPS Est. Cur. Y

2.07

EPS Next Y. (Est.)

2.48

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

15.96

Relative Volume

0.98

Return on Equity vs Sector %

-0.5

Return on Equity vs Industry %

8.4

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

-16.7

DexCom, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 10200

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Stelo, a new over-the-counter glucose biosensor designed for adults with prediabetes and Type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

stock quote shares DXCM – DexCom, Inc. Stock Price stock today

news today DXCM – DexCom, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch DXCM – DexCom, Inc. yahoo finance google finance

stock history DXCM – DexCom, Inc. invest stock market

stock prices DXCM premarket after hours

ticker DXCM fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: DXCM

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y